Aims: This systematic review and meta-analysis aimed to evaluate the effects of cognitive-behavioural therapy in patients with inflammatory bowel diseases.
| INTRODUCTION
Inflammatory bowel diseases (IBD) are a group of inflammatory disorders of the gastrointestinal tract and chronic relapsing disorders with various physical and psychological symptoms (Levine & Burakoff, 2011) . The most frequent phenotypes of IBD are Crohn's disease (CD) and ulcerative colitis (UC). IBD patients suffer from gastrointestinal manifestations, such as diarrhoea, abdominal pain, absorbing barrier, and weight loss, as well as often undergo various levels of psychological disorders due to the complicated interactions between biological mechanisms and psychosocial issues (Filipovic & Filipovic, 2014) .
Related researches also suggested that IBD patients with difficulty to adjust to disease-related demands perform more bowel or systemic symptoms, have higher perceived stress, more psychological distress, and less engagement in activities (Kiebles, Doerfler, & Keefer, 2010) .
The relationship between IBD and psychiatric disorders has been researched in the past few years. Patients affected by IBD have a high rate of psychological distress, such as depression and anxiety (A. M. McCombie, Mulder, & Gearry, 2015) . Research increasingly suggests that individuals living with IBD frequently report anxiety and depression (Bennebroek Evertsz et al., 2012; Knowles, Wilson, Connell, & Kamm, 2011) , and a review has indicated that anxiety and depression have a negative effect on IBD course (Graff, Walker, & Bernstein, 2009 ).
Psychosocial stressors have been indicated as triggers in flare-ups of IBD symptoms and have devastating effects on IBD patients (Maunder & Levenstein, 2008) . A range of studies have reported that quality of life (QOL) is remarkably impaired among IBD patients (Cohen et al., 2014; Iglesias-Rey et al., 2014; Lix et al., 2008) , and poor QOL is further associated with IBD symptom relapse or exacerbation (Levenstein, 2004) .
Cognitive-behavioural therapy (CBT), as one of the most extensively studied methods of psychotherapy, refers to teaching patients to modify maladaptive behaviours by identifying and modifying unhelpful thinking styles (Aaron T Beck, 1976) . CBT is used for a wide range of psychiatric disorders and has been reported as useful to reduce psychological distress in mental illness, such as depression, anxiety, and schizophrenia (Lynch, Laws, & McKenna, 2010; Milev, Ho, Arndt, & Andreasen, 2005; Stanley et al., 2009) , as well as in chronic medical conditions such as chronic pain and cancer (Antoni et al., 2001; Ehde, Dillworth, & Turner, 2014) . Some randomized controlled trials (RCTs) of CBT have been conducted in irritable bowel syndrome, and a report indicates that CBT is a beneficial treatment for patients with irritable bowel syndrome (Ford et al., 2014) .
As far as we know, there is little research on CBT in IBD, and the results remain inconsistent. There is no meta-analysis of the efficacy of CBT in IBD patients. The overall goal of a meta-analysis is to combine the results of previous studies to arrive at a summary conclusion about a number of research studies. Therefore, we conducted the present review and meta-analysis to appraise the efficacy of CBT in IBD patients.
| METHODS
We followed the methodology standards according to the Preferred Reporting Items for Systematic reviews and Meta-Analysis guidelines 
| Types of interventions
This meta-analysis considered studies evaluating the effects of cognitive-behavioural therapy in patients with IBD with usual or standard treatment.
| Types of outcomes
Outcomes included at least one of the following items: quality of life, disease activity, anxiety, and perceived stress.
| Types of studies
This current meta-analysis included controlled trials, particularly RCTs.
Reviews, abstracts, protocol, and duplicate publications were excluded.
Study language was limited to English.
| Search strategy
To identify potentially eligible studies from inception to June 2017, we systematically searched multiple electronic databases including Cochrane Library, Web of Science, Pubmed, EMBASE, and CINAHL, with English language restriction. The terms "cognitive behavioral therapy," "behavioural therapy," "cognitive therapy," "inflammatory bowel disease," "Crohn's Disease," "ulcerative colitis," "CBT," "CD,"
and "UC" jointly used as MeSH terms or free texts terms. Furthermore, we also conducted additional search from grey literature databases and manual searches of retrieved articles.
| Data extraction
All relevant data were screened independently by two reviewers. The following information was extracted from each study including the first author's name, publication year, origin country, patients' characteristics (such as age, gender, and duration of IBD), sample size, intervention characteristics (such as procedure, dose, and duration of treatment), duration of follow-up, and relevant clinical outcomes. All the data were reviewed by the third reviewer, and uncertainty or disagreement was resolved by discussion.
| Quality assessment
Two reviewers did quality assessment of eligible literatures independently by using the modified Jadad scale for RCTs (Oremus et al., 2001 ). The modified Jadad scale comprised randomization, blinding, withdrawals/dropouts, inclusion/exclusion criteria, adverse effects, and statistical analysis. 0 (no) or 1 (yes) was scored in each item, while in two items (randomization and blinding appropriate), 1 indicated yes or no and 0 indicated not described. The global ideal score was 8.
Scores above four points and scores under three points indicated good and poor quality, respectively (Oremus et al., 2001 ). 
| Outcomes of interest and definition

| Primary outcome
In five studies, IBDQ score was compared between CBT group and control group at the final follow-up point (Berrill et al., 2014; Boye et al., 2011; Keefer et al., 2012; Schoultz et al., 2015) . Analysis of the pooled data shows that IBDQ score was higher in the CBT group than in control group at the final point of follow-up. IBDQ score differed significantly in the two groups in this regard (WMD = 9.48, 95% CI: 2.45-16.51; P = 0.008), using fixed-effect model, with heterogeneity (I 2 = 21.9%; P = 0.275), but the evidence is limited, and it does not reach the predetermined clinically significant differences of 20 (Figure 2 ).
FIGURE 1 Flow chart of included studies
| Secondary outcome
Three studies used CDAI to measure the disease activity of CD patients (A. McCombie et al., 2016; Mikocka-Walus et al., 2015; Schoultz et al., 2015) . As shown in Table 3 and Trait Anxiety (STAIY2) scores show no significant difference between the two groups. As can be seen in Table 2, STAIY1 (WMD = −0.07, 95% CI: −9.04-8.91; P = 0.988), is evaluated by using fixed-effect model, with heterogeneity (I 2 = 0.0%; P = 0.678), and STAIY2 (WMD = 1.94, 95% CI: −7.29-11.17; P = 0.681), is evaluated by using fixed-effect model, with heterogeneity (I 2 = 0.0%; P = 0.693).
Levels of perceived stress were evaluated using PSQ in two studies at the final point of follow-up (Berrill et al., 2014; Keefer et al., 2012) . The CBT had no significantly greater improvements in PSQ score (WMD = 0.00, 95% CI: −0.11-0.12; P = 0.936), using fixed-effect model, with heterogeneity (I 2 = 32.9%; P = 0.222) ( Table 3) . Figure 3 shows a funnel plot of the studies included in the meta-analysis that reported IBDQ. All studies lie inside the 95% CIs, with an even distribution around the vertical, indicating no obvious publication bias (P = 0.980).
| Publication bias
| DISCUSSION
This study aimed to examine the feasibility, acceptability, and effectiveness of CBT. The major findings of the meta-analysis provide consistent evidence that the use of CBT for IBD patients improves quality of life. As a result, this approach can be an acceptable adjunctive therapy for IBD patients.
Cognitive-behavioural therapy, as one of most extensively psychology researched areas, is now used for other disorders including anxiety, panic attacks and IBD (Hofmann & Smits, 2008; Schoultz et al., 2015) . It is a collaborative psychological approach that addresses the interaction between people's cognition and behaviours (A. T. Beck & Clark, 1997) . The purpose of CBT is to modify the disorder of negative automatic thinking and potential awareness or belief, thereby changing the behaviour pattern (Ciarrochi, Robb, & Godsell, 2005) . With the development of CBT, it has been used for IBD patients. As far as we know, this is the first meta-analysis providing comprehensive view into the effects of the CBT associated with IBD patients. In this meta-analysis, we analysed the efficacy of CBT in IBD patients using a meta-analysis to obtain a powerful conclusion.
According to this meta-analysis, we can see that CBT benefits IBD patients of QOL, but not the disease activity, anxiety, and perceived stress.
According to this meta-analysis, the primary findings of this metaanalysis reveal that CBT is associated with a higher QOL of IBD patients at the final point of follow-up when pooling data from 341 IBD patients, but the improvement is limited as it does not reach the predetermined clinically significant differences of 20 (Berrill et al., 2014) .
Three studies involving 143 participants (59 in CBT group and 84
in control group) performed disease activity in CD patients and four FIGURE 3 Funnel plot depicts the distribution of weighted mean difference comparing IBDQ in the meta-analysis studies involving 92 participants (46 in CBT group and 46 in control group) performed disease activity in UC patients. And our meta-analysis provides no support for the hypothesis that CBT is associated with improvement of disease activity.
Further, and interestingly, this meta-analysis shows that participants who received CBT were not found to differ in anxiety and perceived stress scores, which is in contrast to usual considerations of CBT, which has the high efficacy in treating mental health disorders (Hans & Hiller, 2013; Zhu et al., 2014) . The reasons that the course of IBD is persistent and related to high relapsing rates may account for this result. IBD patients have a high rate of developing depression and anxiety, there is a clear relationship between IBD disease activity and anxiety scores (Bennebroek Evertsz et al., 2012; Knowles et al., 2011; A. M. McCombie et al., 2015) . This intervention cannot alleviate disease activity of IBD, and whether this then influences anxiety and perceived stress. Due to the unremitted disease activity, CBT also has no effect on anxiety and perceived stress.
| Limitations
This meta-analysis incorporates high quality RCTs and the reliability of results can be demonstrated. However, some limitations in this metaanalysis should be mentioned. First, the studies included in this analysis are insufficient, especially in terms of subgroup analysis, and it is very likely there is publication bias despite no evidence obtained from our statistical tests. Secondly, study language was limited to English, which may lead to potential language bias. Lastly, the inherent limitations of included studies prevent us from obtaining more definitive conclusions. Future well-designed RCTs are required to confirm and update the findings of this meta-analysis.
| CONCLUSION
This meta-analysis has indicated that CBT appears to have a positive effect on QOL in IBD patients compared with control group at the final follow-up point. However, it does not improve disease activity, anxiety, or perceived stress in patients with IBD. Our results suggest that CBT can be an acceptable adjunctive therapy for IBD patients.
These results have particular implications for nursing, as nurses have a key role in supporting patients with IBD, and CBT is commonly and successfully used by nurses. Further training will be required for nurses to adopt and apply CBT for these patients.
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